Cannabis sativa extracts demonstrate potential to in COVID-19 treatment

By Akshay Kedari  Date: 2020-04-23

Cannabis sativa extracts demonstrate potential to in COVID-19 treatment

The University of Lethbridge, with Swysh, a company focused on cannabinoid R&D and Pathway Rx, a research company focused on developing custom cannabis therapies, are partnering to unravel a specific Cannabis sativa extract that shows potential as an additional treatment for the novel coronavirus.

Dr. Igor Kovalchuks, Chief Executive Officer at Pathway RX and Dr. Olga Kovalchuk, (both are professors at The University of Lethbridge) reportedly said that although one of their most successful cannabis sativa extracts require further validation in an animal model as well as in a large-scale analysis, the study is crucial for the examination of the effects of medical cannabis on coronavirus.

A team of researchers and Kovalchuks recently submitted their paper to a journal for publication. The paper represents extensive research study on the effects of medical cannabis on COVID-19. The manuscript of the paper has been uploaded on Preprints. However, it signifies that the research has not yet been peer reviewed or been published in a journal.

As per sources close to the matter, the study is focused on how different cannabis extracts affect TMPRSS2 and ACE2 proteins. These proteins are rooted into the cellular membrane and are the main gateway for the coronavirus to enter host cells. Used by the researchers, the C. sativa has been analyzed for modulating the levels of these enzymes.

Initial data indicate that 13 cannabis sativa extracts which are high in the anti-inflammatory cannabinoid cannabidiol can modulate ACE2 expression in coronavirus target tissues and may also down-regulate TMPRSS2 proteins. The results establish that these high-cannabinoid C. sativa lines showcase potential to be a safe and useful addition for the treatment of COVID-19.

Estimates suggests that they could be potentially utilized to develop preventative treatments in the form of a throat gargle or mouthwash product for clinical as well as home use.

 

Source credit: https://www.uleth.ca/unews/article/u-l-scientists-develop-new-medical-cannabis-cultivars-show-promise-combatting-covid-19-virus#.XqEcDGYzbcu

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Facebook ad revenue could face more brunt over Apple’s privacy changes

Facebook ad revenue could face more brunt over Apple’s privacy changes

By Akshay Kedari

After Snap Inc. failed to reach its revenue targets last week, investors are now fearing that Facebook’s ad revenue could also be severely impacted due to Apple’s privacy changes. For those unaware, Apple’s privacy updates, which w...

Mark Zuckerberg planning to rebrand Facebook to reflect metaverse focus

Mark Zuckerberg planning to rebrand Facebook to reflect metaverse focus

By Akshay Kedari

There have been many businesses that have rebranded themselves to alter their identity with time. Following the league, social networking giant Facebook is also reportedly planning to rebrand the firm with a new name. On October 28, Chief Executive ...

Formula One teams to test second-generation biofuel during 2022 season

Formula One teams to test second-generation biofuel during 2022 season

By Akshay Kedari

The leading motorsport intends to achieve net-zero carbon status by the end of this decade. F1 has ruled out switching to an all-electric powertrain such as in Formula E. With increasing significance towards green mobility, Formula One teams are...

Apple’s iPhone 13 production may take a hit due to global chip shortage

Apple’s iPhone 13 production may take a hit due to global chip shortage

By Akshay Kedari

Apple Inc. is likely to cut down production of its iPhone 13 model by approximately 10 million units on account of the global chip shortage. The American multinational technology company was previously expected to manufacture 90 million units of the ...

Israel's GoTo Global acquires German e-moped sharing platform emmy

Israel's GoTo Global acquires German e-moped sharing platform emmy

By Akshay Kedari

Israel-based multimodal vehicle sharing services provider GoTo Global Mobility Ltd. has reportedly acquired Germany’s shared e-scooter company emmy. The acquisition will allow GoTo Global to enter the German market as well as accelerate its Eur...